Yan Liu, M.D., Ph.D.

Yan Liu, M.D., Ph.D., is a board-certified cardiologist, cardio-oncologist and the director of cardio-oncology service line at Ascension Texas. He specializes in cardio-oncology, general cardiology, cardiovascular imaging and vascular medicine.

Prior to joining Dell Medical School, Liu was an assistant professor of medicine at the University of North Carolina at Chapel Hill and served as the system director of the cardio-oncology service line at Sentara Healthcare. He completed his residency training in internal medicine at UT Southwestern Austin Programs. He then completed his cardiology fellowship and served as the chief cardiology fellow at the University of North Carolina at Chapel Hill Hospitals. Liu also received a doctorate in immunology at Duke University and completed his oncology postdoctoral research fellowship at the Lineberger Comprehensive Cancer Center in UNC-Chapel Hill through the Joseph Pagano Fellowship award.

Liu’s research is focused on the novel molecular pathways in cardiovascular disease and cancer, leading to innovative therapy and drug development in cardiovascular disease and cardio-oncology. He served as the principal investigator in several investigator-initiated original clinical studies funded by national nonprofit agencies. He has authored more than 40 peer-reviewed scientific papers with over 3000 citations. He is an inventor on several patents that lead to two clinical-stage biopharmaceutical companies and a Food and Drug Administration-approved, guideline-recommended, first-in-class chemoprotection drug — the first and only myeloprotection therapy up to date. Liu’s prior research established p16INK4a as the key molecular mechanism linking cancer and heart disease, setting the molecular foundation for cardio-oncology as a novel clinical specialty. His most recent innovation involves a novel cardio-oncology service line care model in improving cardio-oncology care quality, access and health equity.

Liu is a fellow of the American College of Cardiology. He has served on numerous committees, editorial boards and scientific boards, including the editor/editorial board of Cardio-Oncology, Journal of Cardio-Oncology, ACO Board at Bayview Health, the cardio-oncology advisory board at Pfizer and the expert panel at Texas Medical Board. He is also the past president of Texas Medical Association Burnet-Lampasas County Medical Society. Liu’s research and innovation have been featured by many major international/national media, including BBC World News, ScienceDaily, Yahoo! News and WebMD.